Jan 7 (Reuters) - Qlife Holding AB QLIFE.ST :
* QLIFE CE-MARKS COVID-19 TEST
* QLIFE ANNOUNCES THAT COMPANY HAS CE-MARKED ITS PCR TEST
FOR
SARS-COV-2 FOR PROFESSIONAL USE ON MOBILE TEST PLATFORM
EGOO.HEALTH AND THAT COMMERCIALIZATION CAN BEGIN IMMEDIATELY.
* CURRENT CE-MARK APPLIES TO PROFESSIONAL USE OF TEST
PLATFORM
EGOO.HEALTH FOR SALE ON EUROPEAN MARKET.
Source text for Eikon: ID:nWkr9LT5Gq
Further company coverage: QLIFE.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))